CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹3,481 Cr | ₹3,134 Cr | ₹2,563 Cr | ₹1,507 Cr | ₹1,031 Cr |
What is the latest Short Term Loans and Advances ratio of CIPLA ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹3,481 Cr |
| Mar2024 | ₹3,134 Cr |
| Mar2023 | ₹2,563 Cr |
| Mar2022 | ₹1,507 Cr |
| Mar2021 | ₹1,031 Cr |
How is Short Term Loans and Advances of CIPLA Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,481 Cr | 11.08 | |
| Mar2024 | ₹3,134 Cr | 22.28 | |
| Mar2023 | ₹2,563 Cr | 70.07 | |
| Mar2022 | ₹1,507 Cr | 46.18 | |
| Mar2021 | ₹1,031 Cr | - | |
Compare Short Term Loans and Advances of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹100,482.2 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| MANKIND PHARMA | ₹83,401.6 Cr | 1% | -1.3% | -11.5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.4% |
-6.2% |
-19.4% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses